Exploration of Copper-Cysteamine Nanoparticles as a New Type of Agents for Antimicrobial Photodynamic Inactivation

Copper-cysteamine (Cu-Cy) nanoparticles (NPs) are a new type of sensitizers that can be activated by UV light, X-rays, microwaves and ultrasound to produce reactive oxygen species for cancer treatment. Here, for the first time, we explored Cu-Cy NPs for bacteria inactivation by treating gram-positive bacteria (methicillin-resistant Staphylococcus aureus and Enterococcus faecalis) and gram-negative bacteria (Escherichia coli and Acinetobacter baumannii), respectively. The results show that Cu-Cy NPs are very effective in killing gram-positive bacteria but are quite limited in killing gram-negative bacteria yet. The major killing mechanism is cell damage by singlet oxygen and Cu-Cy NPs are potential agents for bacteria inactivation.

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:15

Enthalten in:

Journal of biomedical nanotechnology - 15(2019), 10 vom: 01. Okt., Seite 2142-2148

Sprache:

Englisch

Beteiligte Personen:

Huang, Liyi [VerfasserIn]
Ma, Lun [VerfasserIn]
Xuan, Weijun [VerfasserIn]
Zhen, Xiumei [VerfasserIn]
Zheng, Han [VerfasserIn]
Chen, Wei [VerfasserIn]
Hamblin, Michael R [VerfasserIn]

Links:

Volltext

Themen:

5UX2SD1KE2
789U1901C5
Anti-Bacterial Agents
Copper
Cysteamine
Journal Article

Anmerkungen:

Date Completed 05.09.2019

Date Revised 14.02.2024

published: Print

Citation Status MEDLINE

doi:

10.1166/jbn.2019.2829

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM300718500